Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.

Neuralink received FDA approval for its first human study in May 2023. The company had expressed on Twitter that this ...

Elon Musk's brain chip firm Neuralink has said that the US Food and Drug Administration (FDA) has approved its first ... many people," Neuralink said in a tweet. It did not elaborate on the ...

SEE MORE: Elon Musk's Neuralink gets FDA approval to start clinical trials ... according to Musk’s tweet. SEE MORE: Ethics group calls for probe into Elon Musk's Neuralink brain implant Watch ...

Announcing Thursday's news on Twitter, Neuralink talked of an "important ... Its announcement on FDA approval for human tests follows recent news of a similar breakthrough involving brain implants ...

Earlier this year, Neuralink said it had implanted its wireless brain-computer interface (BCI) device into a human being for the first time, following FDA approval of clinical trials last year ...

Science Corporation says its retinal implant restored central vision in patients who were legally blind in a clinical trial.

Neuralink's second brain implant shows promise as the company aims to enhance the quality of life for individuals with spinal ...

[Twitter] Elon Musk said on ... that he hoped to start human trials this year. Neuralink has repeatedly missed internal deadlines to gain FDA approval to start human trials, current and former ...

The world's richest person could get a lot of help with contracts and regulatory headaches during the Trump administration.

The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...

Elon Musk’s brain-chip company Neuralink has received the FDA's “breakthrough device” designation for its experimental vision-restoring implant, Blindsight. The designation, announced on ...